ArticleBritish journal of cancer2026

Alectinib boosts anti-tumor efficacy of disialoganglioside 2 chimeric antigen receptor T cells in ALK-mutated neuroblastoma by suppressing programmed death-ligand 1.

Yuya Sugitatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.